Data Management

A high performing team of global clinical data management experts.

Everyone on the MMS team has been so collaborative and responsive. It is rare to have such a seamless experience.
Biometrics Leader
Large Pharmaceutical Partner

Driven by quality, the experts at MMS approach every biometrics deliverable as a top priority, no matter the size or scope of the project. You and your team can expect in-depth, thoughtful conversations with team members, knowing that they are thought leaders, invited speakers, and change makers in industry groups across the globe.

Certified in multiple industry esteemed EDC platforms, allowing for flexible approach to database builds and efficiencies to tailor to Sponsor requirements as projects progress.

Data Management services at MMS are designed to streamline  the process of design, collection, reconciliation, and review of clinical research data. Our clinical data specialists manage all aspects of the data while you stay in complete control — with continuous access to data and total transparency to study progress.

Working with MMS brings:

  • An experienced, award-winning team to manage studies across a variety of industry leading EDC platforms, including accreditations to build in Rave, Zelta, and Medrio
  • Expertise to recommend and deploy cutting-edge “e” technologies, including eCOA (eClinRO and ePRO), eDiary, and eConsent 
  • A wide range of therapeutic area expertise
  • Proven processes to begin clinical studies faster, with accurate, clean results that exceed expectations
  • Near real-time access to clean clinical data, including added visibility via Datacise technology
  • A single point of contact, reducing communication burden and increasing historical knowledge

MMS Clinical Data Managers provide: 

  • Expert knowledge on EDC technology and surrounding processes
  • Clean, reproducible fit-for-analysis data, with cross functional support from the entire biometrics team
  • Lead Data Managers that rise to the challenge of aggressive study timelines
  • Knowledge transfer and industry-leading CRO retention rates increase efficiencies to propel study conduct to the finish line while ensuring data integrity

Suggested For You

news

February 5th, 2026

MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions 

perspectives

February 3rd, 2026

A Conversation with MMS Founder and CEO Dr. Uma Sharma: Building MMS: 20 Years of People-First, Data-Led Drug Development 

news

January 29th, 2026

Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

ebook

January 27th, 2026

A Practical Guide to Expedited Regulatory Pathways

perspectives

January 27th, 2026

What Regulators Want to See in Surrogate Endpoints Today 

perspectives

January 20th, 2026

Behind the Scenes of Global Regulatory Submission Planning is a Symphony of Collaboration 

perspectives

January 13th, 2026

Making Clinical Trial Technology Work in Practice

fact sheet

December 17th, 2025

Advance Psychedelic Drug Development With Proven Regulatory and Data Expertise

fact sheet

December 17th, 2025

Agile Medical Writing Staff Augmentation When You Need Expertise Not Headcount

fact sheet

December 17th, 2025

Biometrics Solutions Fact Sheet: End-to-End Data Expertise for Complex Clinical Trials

whitepaper

December 17th, 2025

Estimands: Opportunity or Risk for Drug Developers?

perspectives

December 16th, 2025

Inside Pharma and Biotech’s Shifting Landscape and the Direction Leaders Are Giving for 2026